Basel Medical Group Ltd Cash And Cash Equivalents
Basel Medical Group Ltd (BMGL) had Cash And Cash Equivalents of SGD 3.04 million as of 2025-06-30, per its 20-F/A filed 2026-03-13.
Financial Statements › Notes
ifrs-full:CashAndCashEquivalents · last filed 2026-03-13
- 2025-06-30: Cash And Cash Equivalents 3.04M SGD; Cash And Cash Equivalents as first filed 2.98M SGD.
- 2024-06-30: Cash And Cash Equivalents 1.95M SGD.
- 2023-06-30: Cash And Cash Equivalents 1.22M SGD.
SGD
| Period end | Cash And Cash Equivalents | Cash And Cash Equivalents as first filed |
|---|---|---|
| 2025-06-30 | 3.04M SGD 20-F/A · filed 2026-03-13 | 2.98M SGD 20-F · filed 2025-11-18 |
| 2024-06-30 | 1.95M SGD 20-F/A · filed 2026-03-13 | |
| 2023-06-30 | 1.22M SGD 20-F/A · filed 2026-03-13 |
USD
| Period end | Cash And Cash Equivalents | Cash And Cash Equivalents as first filed |
|---|---|---|
| 2025-06-30 | $2.39M 20-F/A · filed 2026-03-13 | $2.34M 20-F · filed 2025-11-18 |
| 2024-06-30 | $1.53M 20-F/A · filed 2026-03-13 |